| |
| |
|
| Insider
Information: |
Sv Life Sciences Fund Iv, L.p. |
| Relationship: |
10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
47,471 |
|
|
Indirect Shares
|
59,350 |
|
|
| Direct
Value |
$573,450 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
106,821 |
|
|
| Total
Value |
$573,450 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Entellus Medical Inc |
ENTL |
10% Owner |
2015-02-03 |
0 |
2015-02-03 |
59,350 |
Premium* |
|
|
Kalvista Pharmaceuticals Inc |
KALV |
10% Owner |
2019-04-10 |
47,471 |
2016-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-04-10 |
4 |
S |
$29.40 |
$397,746 |
D/D |
(13,531) |
47,471 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-04-09 |
4 |
S |
$28.53 |
$389,983 |
D/D |
(13,669) |
47,845 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-04-08 |
4 |
S |
$29.49 |
$672,415 |
D/D |
(22,800) |
48,222 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-04-02 |
4 |
S |
$28.76 |
$262,930 |
D/D |
(9,141) |
48,851 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-04-01 |
4 |
S |
$27.66 |
$1,461,210 |
D/D |
(52,831) |
49,104 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-03-29 |
4 |
S |
$28.40 |
$996,756 |
D/D |
(35,102) |
50,562 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-03-28 |
4 |
S |
$27.80 |
$1,019,324 |
D/D |
(36,665) |
51,531 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-03-27 |
4 |
S |
$29.06 |
$1,683,022 |
D/D |
(57,917) |
52,543 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-03-26 |
4 |
S |
$29.70 |
$893,687 |
D/D |
(30,093) |
54,142 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-03-18 |
4 |
S |
$26.70 |
$7,007,949 |
D/D |
(262,470) |
54,973 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-03-05 |
4 |
S |
$23.04 |
$744,816 |
D/D |
(32,332) |
62,219 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-03-04 |
4 |
S |
$22.91 |
$993,660 |
D/D |
(43,378) |
63,112 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-02-21 |
4 |
S |
$20.60 |
$3,554,386 |
D/D |
(172,543) |
64,309 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-02-20 |
4 |
S |
$20.02 |
$465,069 |
D/D |
(23,235) |
69,073 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-02-19 |
4 |
S |
$20.73 |
$381,898 |
D/D |
(18,420) |
69,714 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-01-07 |
4 |
S |
$20.41 |
$53,051 |
D/D |
(2,599) |
70,222 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-01-03 |
4 |
S |
$20.01 |
$34,022 |
D/D |
(1,700) |
70,294 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2019-01-02 |
4 |
S |
$20.00 |
$4,000 |
D/D |
(200) |
70,341 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2018-12-31 |
4 |
S |
$20.00 |
$508,462 |
D/D |
(25,418) |
70,347 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2018-12-28 |
4 |
S |
$20.03 |
$74,781 |
D/D |
(3,734) |
71,049 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2018-12-19 |
4 |
S |
$20.02 |
$42,758 |
D/D |
(2,136) |
71,152 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
– – • |
2016-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,579,490 |
71,211 |
0 |
- |
|
| ENTL |
Entellus Medical Inc |
10% Owner |
– – • |
2015-02-03 |
4 |
B |
$17.00 |
$5,399,999 |
I/I |
317,647 |
59,350 |
1.5 |
- |
|
| ENTL |
Entellus Medical Inc |
10% Owner |
– – • |
2015-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
3,171,884 |
50,581 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
